Sheri L Booten

Author PubWeight™ 18.52^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting.	Cell Metab	2006	12.41
2	Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.	Hepatology	2005	2.25
3	Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys.	Endocrinology	2009	1.00
4	Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice.	J Clin Invest	2013	0.94
5	Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.	Am J Physiol Endocrinol Metab	2008	0.86
6	Reduction of JNK1 expression with antisense oligonucleotide improves adiposity in obese mice.	Am J Physiol Endocrinol Metab	2008	0.86
7	Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease.	J Biol Chem	2007	0.81